QUEBEC (CP) - Drug maker AEterna Zentaris Inc. said Wednesday its Impavido treatment for the skin-affecting form of the disease leishmaniasis has been approved by the Colombian Food and Drug Agency....More
Thursday, March 24, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment